Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- All SEC Filings
All SEC Filings
| Date | Form | Description | Docs | XBRL | Pages |
| 08/15/13 | 4 | Rhodes John B |
|
2 | |
| 08/15/13 | 4 | Mario Ernest |
|
2 | |
| 08/15/13 | 4 | Lederman Seth |
|
2 | |
| 08/15/13 | 4 | Daugherty Bruce |
|
2 | |
| 08/14/13 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
|
29 |
| 08/14/13 | 8-K | Current report filing |
|
6 | |
| 08/14/13 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
11 | |
| 08/13/13 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
18 | |
| 08/09/13 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
129 | |
| 08/09/13 | 8-K | Current report filing |
|
5 |
